Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy

Pediatrics. 2024 Jul 1;154(1):e2023065512. doi: 10.1542/peds.2023-065512.
No abstract available

MeSH terms

  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / therapeutic use
  • Cerebral Palsy* / complications
  • Cerebral Palsy* / drug therapy
  • Child
  • Dystonia* / drug therapy
  • Dystonia* / etiology
  • Humans

Substances

  • Botulinum Toxins, Type A